MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregula | OTT
MET and TP 53: How They Relate to ALK Lung Cancer — ALK POSITIVE
MET Signaling: Novel Targeted Inhibition and Its Clinical Development in Lung Cancer - ScienceDirect
new-molecular-drivers-in-nsclc-the-role-of-met
Capmatinib for patients with non-small cell lung cancer with MET exon 14 skipping mutations: A review of preclinical and clinical studies - Cancer Treatment Reviews
Targeting MET in Lung Cancer: Will Expectations Finally Be MET? - ScienceDirect
Targeting MET: Discovery of Small Molecule Inhibitors as Non-Small Cell Lung Cancer Therapy | Journal of Medicinal Chemistry
Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752 | PNAS
Targeting MET in Cancer: Obstacles and Potentials
IJMS | Free Full-Text | Targeting MET in Non-Small Cell Lung Cancer (NSCLC): A New Old Story?
Refining patient selection of MET-activated non-small cell lung cancer through biomarker precision - ScienceDirect
Met signaling pathway and EGF receptor tyrosine kinase inhibitor... | Download Scientific Diagram
EMT, MET amplification, and IGF-1R confer resistance to EGFR TKIs.... | Download Scientific Diagram
MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer | Journal of Hematology & Oncology | Full Text
MET gene analysis by next-generation sequencing & fluorescence | Oncotarget
Cancers | Free Full-Text | MET Amplification as a Resistance Driver to TKI Therapies in Lung Cancer: Clinical Challenges and Opportunities
Beyond epidermal growth factor receptor: MET amplification as a general resistance driver to targeted therapy in oncogene-driven non-small-cell lung cancer - ESMO Open
Read in JCO:... - American Society of Clinical Oncology | Facebook
Reciprocal relationship between MET amplification and T790M mutation.... | Download Scientific Diagram
An overview of the c-MET signaling pathway - Shawna Leslie Organ, Ming-Sound Tsao, 2011
Detection of MET amplification by droplet digital PCR in peripheral blood samples of non-small cell lung cancer | SpringerLink
MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer | Journal of Hematology & Oncology | Full Text
Cancers | Free Full-Text | Targeting MET Amplification as a New Oncogenic Driver
The role of MET in chemotherapy resistance | Oncogene
The multiple paths towards MET receptor addiction in cancer | Oncogene
MET amplification causes EGFR-TKI resistance by activating... | Download Scientific Diagram
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling | Science
